In town for PEGS Boston by the Cambridge Healthtech Institute? Make sure to attend our luncheon presentation:

The Development of NeoMab™: A Novel Mouse Model to Facilitate Fully Human Antibody Development 

Mingkun Zhang, Director, NeoMab™ Platform, GemPharmatech

Antibodies and their derivatives have proven significant effectiveness against human diseases, but challenges like immunogenicity and engineering failures hinder their progress. GemPharmatech's platform, based on humanized transgenic animal models, addresses these issues, and enable the efficient development of therapeutic antibodies. This presentation will share the development and validation of these models, as well as case studies for antibody discovery.